4//SEC Filing
PROGENICS PHARMACEUTICALS INC 4
Accession 0001266375-07-000052
CIK 0000835887operating
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 5:25 PM ET
Size
15.9 KB
Accession
0001266375-07-000052
Insider Transaction Report
Form 4
Kremer Alton B
VP, Clinical Research
Transactions
- Award
Common Stock
2007-07-02+13,333→ 29,349 total - Tax Payment
Common Stock
2007-07-02$22.01/sh−775$17,058→ 29,426 total - Exercise/Conversion
Common Stock
2007-07-02$18.71/sh+852$15,941→ 30,201 total - Exercise/Conversion
ESPP (right to buy)
2007-07-02−852→ 0 totalExercise: $18.71From: 2007-07-02Exp: 2007-07-03→ Common Stock (852 underlying) - Award
ESPP (right to buy)
2007-07-02+753→ 753 totalExercise: $21.57From: 2008-01-02Exp: 2008-01-02→ Common Stock (753 underlying) - Award
Non-Qualified Stock Option (right to buy)
2007-07-02+10,000→ 10,000 totalExercise: $22.01From: 2008-07-02Exp: 2017-07-02→ Common Stock (10,000 underlying)
Footnotes (7)
- [F1]Restricted Stock shall be released in four equal installments, commencing one year from the transaction date.
- [F2]Includes shares of common stock acquired from the non-reportable exercise under a Qualified Employee Stock Purchase Plan.
- [F3]Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise.
- [F4]The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. The number of shares exercised is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date.
- [F5]Granted under the Company's Non-Qualified Employeee Stock Purchase Plan.
- [F6]The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the day prior to the exercise date.
- [F7]The stock options become exercisable in four equal installments, commencing one year from the grant date.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000835887
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 5:25 PM ET
- Size
- 15.9 KB